Double Marker test

Our Double Marker Test is a prenatal screening test performed during early pregnancy to assess the risk of certain chromosomal abnormalities in the fetus, including Down Syndrome and Edwards Syndrome. This test plays a vital role in early detection and helps guide further diagnostic decisions.

The test measures two important markers in the mother’s blood: Free Beta-hCG and PAPP-A (Pregnancy-Associated Plasma Protein-A). It is usually conducted between 9 to 14 weeks of pregnancy and is often combined with ultrasound findings for more accurate risk assessment.

Key Benefits:
• Screens for chromosomal abnormalities in early pregnancy
• Supports early detection and timely medical decisions
• Non-invasive and safe for both mother and baby
• Helps doctors plan further diagnostic tests if required